Improving Safety, Efficiencies, and Reducing Waste with Ready-to-Administer IV Medications: A Roadmap to Success
Many organizations have stated that to avoid the unnecessary, error-prone complexity of IV push medication preparation and administration, and to avoid the risk of contamination and personnel exposure, organizations should re-evaluate current products administered by IV push and standardize as much as possible to ready-to-administer (RTA) formulations and concentrations.
This webinar will describe reported key safety vulnerabilities associated with IV push medication dose manipulation and challenges with waste management that have led to errors and patient harm. The faculty will explain the benefits of analyzing the cost and time inefficiencies associated with wasting opioids, along with the secondary benefit of reducing diversion opportunities. Methods for optimizing ADC storage in anticipation of adoption of manufacturer-prepared prefilled ready-to-administer (RTA) products will be shared. Lastly, this webinar will provide practitioners insight into the necessary decision making and implementation steps required when transitioning to a manufacturer-prepared prefilled RTA syringe product including the standardization of opioid dosing, and the beneficial impact on safety and nursing workflow.
Medication Safety and Patient Safety Officers
Risk Management and Quality Managers
Medication Safety Committees
Following completion of this activity, participants will be able to:
Review the safety challenges and diversion risks associated with the preparation and administration of IV push medications doses that require product manipulation.
Outline the steps taken and data used to optimize automated dispensing cabinets (ADC) storage capacity in anticipation of the transition to RTA syringes.
Describe one organization's successful journey towards medication safety, waste reduction, and workflow efficiencies, when adopting RTA syringes.
Satya Krishna Ramachandran, MD, Director of Pharmacy, Associate Professor, Harvard Medical School, Anesthesiologist, Beth Israel Deaconess Medical Center
Michele A Sheaffer, RPh, Associate Director of Pharmacy Operations at Jefferson Abington Hospital
This activity is supported by Fresenius Kabi.
In support of improving patient care, this activity has been planned and implemented by Partners for Advancing Clinical Education (PACE) and Institute for Safe Medication Practices. PACE is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Pharmacy Continuing Education
PACE designates this continuing education activity for 1.0 contact hour(s) (0.10 CEUs) of the Accreditation Council for Pharmacy Education. (Universal Activity Number - JA4008073-9999-24-009-L05-P/T)
Type of Activity: Knowledge
This activity has been approved for up to 1.0 California State Nursing contact hours by the provider, Debora Simmons, who is approved by the California Board of Registered Nursing, Provider Number CEP 13677. Credit will only be issued to individuals that are individually registered and attend the entire program.